Sitagliptin does not reduce the risk of cardiovascular...

Cardiovascular Diabetology 2019 / 12 Vol. 18; Iss. 1

Sitagliptin does not reduce the risk of cardiovascular death or hospitalization for heart failure following myocardial infarction in patients with diabetes: observations from TECOS

Nauck, Michael A., McGuire, Darren K., Pieper, Karen S., Lokhnygina, Yuliya, Strandberg, Timo E., Riefflin, Axel, Delibasi, Tuncay, Peterson, Eric D., White, Harvey D., Scott, Russell, Holman, Rury R.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
18
Language:
english
Journal:
Cardiovascular Diabetology
DOI:
10.1186/s12933-019-0921-2
Date:
December, 2019
File:
PDF, 958 KB
english, 2019
Conversion to is in progress
Conversion to is failed